NLARx Newsletter Header
NLARx News
July 26, 2010
In This Issue
NLARx Summer Meeting
News from the States
Outrage of the Week
Pharmaceutical Pricing
Conflicts of Interest
Advertising & Marketing
Pharma Watch
PBM Watch
Patents & Generics
Medicare & Medicaid
Safety & Clinical Trials
NLARx on Facebook
Quick Links
Join Our Mailing List
The NLARx Summer Meeting is Just Around the Corner!
Portland PierWhere is the summer going? Its time to register for our August 18 meeting in Portland, Maine. We have experts lined up to give you the inside scoop on how to deal with Medicaid rebate changes in the Affordable Care Act, changing Meicare Part B & D prescription drug benefits, and the role of the States after theLearn the latest on what states are doing to lower drug costs and implement federal health reform including changes to Medicaid rebates and the Sunshine Act. Registration and meeting details: more
News from the States
Massachusetts: Massachusetts House Votes to Repeal Gift Ban; will Vermont Follow? more
Florida:
Florida To FDA: No Foster Kids In Psychotropic Trials more
Maryland
: Maryland Scoops up $26 Million in Waste, Fraud more
Pennsylvania:
Pennsylvania, Pittsburgh Doctors get Millions from Drugmakers more
Outrage of the Week - Avandia
Avandia: A Scandalous Past and an Uncertain Future more
Glaxo Takes a $2.4B Legal Charge on Avandia & Paxil more
Baylor College Probes Avandia and Ghostwriting more
FDA Issues Hold on Avandia Study more
FDA Panel Members Talk About Avandia Conflicts more
Doctor Paid By Takeda was on Avandia Panel more
Glaxo Hid a Study on Avandia Risk for a Decade more
GSK'S Coverup of Avandia's Heart Risk Data: Is This How the Entire Industry Views it's Responsibility to Patients? more
Diabetes Drug Maker Hid Test Data, Files Indicate more
An Avandia Study Author . . . Or So We Thought more
Pharmaceutical Pricing
Eli Lilly CEO Says U.S. Drugmakers' Biggest Challenge Is Sustaining Innovation more
Med School Students Make Different Decisions When They Consider Health Costs more
Conflict of Interest, CME, and Academic Detailing
Harvard Med Bolsters COI Policy: Will Other Schools Follow Suit? more
Two More Med Schools to End Pharma Funding more
University of Wisconsin Docs Hated Conflicts Policy more
Advertising and Marketing
While Doctors get Drug Reps' Soft Sell, Consumers get the Hard Sell more
How Not to Create a Patient Brochure more
Marketing Mexican Medicine To U.S. Patients more
Applying A Supermarket Strategy To Patient-Specific Marketing more
Takeda Launches Actos DTC Campaign Today more
Prescription Drug Websites Need More Regulation? more
A Psychiatrist's Prescription For His Profession more
Pfizer Board Liable for Marketing Miscues, Suit Says more
Pharma Watch
Teva Pays $169M to Settle Medicaid Fraud Charges more
Pfizer & Other Drugmakers Face Price Fixing Lawsuit more
J&J'S 2010 Price Tag for Recalls: $600 Million. But What About Reputation? more
What J&J and Merck did Wrong at Their Plant more
Johnson & Johnson gets Subpoena Over Recalls more
Glaxo to Pay $1B to Settle Paxil Birth Defect Cases more
PhRMA Names Business Roundtable Head As New President, Looks To New Influence more
PBM Watch
CVS Caremark, Walgreens Mend Fences with New Network Deal more
Health Care Losers: Medco and Express Scriptsmore
Pharmacists Back Measures to Cut Feds' Prescription Drug Costs more
PBMs Win a Big Court Ruling over Disclosures more
Patents and Generics
How Brand-Name Drugmakers Fight Generics more
Health Experts And Republicans Push For Biosimilar Drug Clinical Trials more
FTC is Slammed in Pay-For-Delay Case more
U.N. Urged to Probe U.S. Trade Stance on Generic Drugs more
Medicare and Medicaid
New Generics: A Shot in the Arm for State Medicaid Programs? more
Medicare Drug Benefit Appears To Help More Seniors With Heart Failure more
Second Round Of Checks To Close Medicare Doughnut Hole Sent Out more
Safety and Clinical Trials
A Record Number of Drugs are Being Tested to Treat Mental Illness more
FDA official has Helped Push Unapproved Medicine off the Shelf more
FDA Weighs Rules for Consumer Genetic Tests more
Drug Safety Experts Call for New Openness more
Subscribe to the NLARx Blog and Join us on Facebook!
For up-to-the-minute posting of news of interest and events, become a fan of NLARx on Facebook here and subscribe to our Blog.